Cardiovascular Risks Associated With Diastolic Blood Pressure and Isolated Diastolic Hypertension

Current Hypertension Reports

Volumn 16, Issue 11, 2014, Pages 1-6

  Li, Yan ^a   Wei, Fang Fei ^a   Wang, Shuai ^a   Cheng, Yi Bang ^a   Wang, Ji Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiovascular risk; Clinical trials; Diastolic blood pressure; Diastolic hypertension; Population study

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; ISOLATED DIASTOLIC HYPERTENSION; ISOLATED SYSTOLIC HYPERTENSION; MIXED HYPERTENSION; PROSPECTIVE STUDY; REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); COMPLICATION; PATHOPHYSIOLOGY; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 84930751575     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0489-x     Document Type: Review

References (27)

1. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629–41.
2. Dahlo¨f B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–5.
3. Amery A, Birkenha¨ger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349–54.
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results of patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA. 1970;213:1143–51.
5. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA. 1974;229:409–18.
6. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97–104.
7. Report by the Management Committee. Lancet. 1980;1:1261–7.
8. US Public Health Service Hospitals Cooperative Study Group. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res. 1977;40 Suppl 1:98–105.
9. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol. 1971;27:335–46.
10. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103:1245–9. This study defined the roles of systolic, diastolic and pulse pressures as risk predictors of coronary heart disease in different age groups. It demonstrated that with advancing age there was a gradual shift from diastolic to systolic blood pressure and eventually to pulse pressure as risk predictors of coronary heart disease. This publication has been influential in shaping the opinion that aging plays an important role in influencing the relation of blood pressure indexes to cardiovascular risk.
11. Stamler J, Neaton JD, Wentworth D. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension. 1989;13(suppl I):I-2–I-12.
12. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757–64.
13. Liu L, Wang JG, Gong L, Liu G, Staessen JA, For the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older patients with isolated systolic hypertension. J Hypertens. 1998;16:1823–9.
14. Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Staessen JA, et al. Association of target organ damage with 24-hour systolic and diastolic blood pressures and hypertension subtypes in untreated Chinese. Hypertension. 2014;63:222–8.
15. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
16. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.
17. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001;104:783–9.
18. Li Y, Wei FF, Thijs L, Boggia J, Asayama K, Hansen TW, et al. Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation. 2014;130:466–74. This is the first study that examined the age dependency of 24–hour systolic and diastolic ambulatory blood pressures as independent risk factors in the general population and assessed the risks associated with ambulatory hypertension subtypes. It adds to previous literature by demonstrating that the risks conferred by ambulatory diastolic and systolic blood pressure were age dependent. It highlighted that in younger people elevated diastolic pressure as assessed by 24 hour ambulatory monitoring is a risk factor that should be treated.
19. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and the risk of stroke in Japanese-American men. Stroke. 1995;26:25–9.
20. Fang J, Madhaven S, Cohen H, Alderman MH. Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects. Hypertension. 1995;26:377–82.
21. Strandberg TE, Salomaa VV, Vanhanen HT, Pitkälä K, Miettinen T. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens. 2002;20:399–404.
22. Hozawa A, Ohkubo T, Nagai K, Kikuya K, Matsubara M, Tsuji I, et al. Prognosis of isolated systolic hypertension and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home. The Ohasama Study. Arch Intern Med. 2001;160:3301–6.
23. Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X, et al. Hypertension subtype and risk of cardiovascular disease in Chinese adults. Circulation. 2008;118:1558–66.
24. Arima H, Murakami Y, Lam TH, Kim HC, Ueshima H, Woo J, et al. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific region. Hypertension. 2012;59:1118–23. This subject-level meta-analyses, which included 346,570 participants from 36 cohort studies in the Asia-Pacific Region, determined the effects of prehypertension and hypertension subtypes on the risks of cardiovascular disease. The results clearly showed that prehypertension and all hypertension subtypes, including isolated diastolic hypertension, significantly predicted increased risks of cardiovascular disease.
25. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis. 1986;29(3 Suppl 1):99–118.
26. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.
27. Sever PS. Simple blood pressure guidelines for primary care. J Hum Hypertens. 1999;13:725–27.